The anticipated size of the mammography market in 2022 was USD 1,741.2 million and is estimated to be USD 1,880.2 million in 2023.
An increase in the approach to breast cancer screening systems and the growing initiatives taken by the government for supporting clinical interpretation are some of the pivotal factors expected to propel the mammography market’s growth.
According to the Future Market Insights report, the mammography market is anticipated to expand at a CAGR of 10.1% between 2023 and 2033, totaling around USD 4,899.7 million by 2033.
Mammography is a modern non-invasive medical imaging and diagnostic technique that uses low-dose X-rays to monitor breast tissues for the presence of tumors. It has become one of the most commonly used techniques for checking abnormalities in the absence of any symptoms. It has significantly aided in reducing breast cancer mortality rates worldwide.
The increasing prevalence of breast cancer across the world along with growing awareness about the benefits of screening and early diagnosis of breast cancer is providing a key impetus to the growth of the mammography market. It is one of the most common forms of cancer among females, worldwide.
Various studies have found that the risk of breast cancer increases with aging and is common in females aged 40 years and above. It is for this reason that medical institutes and organizations like the American College of Radiology (ACR) and the National Comprehensive Cancer Network (NCCN) have recommended mammography screening for women every year, beginning at age 40. This might continue to act as a catalyst for market growth in the future.
Various mammography solutions or types such as breast tomosynthesis, film screen systems, and X-rays are being used for the early diagnosis of breast cancer. However, film screen systems or screen-film mammography remains the gold standard for the detection of breast cancer.
Various government and non-government organizations are spending large amounts on increasing breast cancer screening and thus reducing the overall burden. This is going to continue to provide tailwinds to market growth in the future. Moreover, the presence of favorable reimbursement policies across many developed regions is positively impacting mammography market growth.
Attributes | Details |
---|---|
Projected Forecast Value (2022) | USD 1,741.2 million |
Projected Forecast Value (2023) | USD 1,880.2 million |
Projected Forecast Value (2033) | USD 4,899.7 million |
Growth rate | 10.1% CAGR |
Forecast period | 2023 to 2033 |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global mammography market expanded at a CAGR of 6.7% between 2018 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 10.1% between 2023 and 2033.
An increase in the endeavors by different state-run administrations and NGOs for advancement in mindfulness concerning early recognition of macro calcifications in breast tissue may be added to advertise extension.
Increasing Breast Cancer Cases
The significant rise in breast cancer cases, technological advancements in breast imaging techniques, and increasing initiatives and investments by government and private organizations for breast cancer monitoring campaigns are some of the key factors driving the global mammography market.
Mammography has emerged as one of the most advanced techniques used for the early diagnosis of breast cancer. Further, it has significantly helped medical agencies to minimize the burden of breast cancer across the world.
The increasing incidence of breast cancer is a significant force behind the expansion of the mammography market. According to the World Health Organization (WHO), an estimated 2.3 million women were diagnosed with breast cancer globally.
Early detection of breast cancer becomes necessary for initiating proper treatment and therefore increasing the chances of survival. For this reason, the mammography technique is being increasingly used across healthcare facilities.
Similarly, factors such as increasing cases of hormonal imbalance, rising geriatric population, and growing awareness among women regarding breast cancer, its diagnosis, and treatment might continue to further push the sales of mammography systems in the future.
Rise in Technological Advancements
Technological advancements in mammography systems such as the development of 3-D imaging solutions (breast tomosynthesis) coupled with an increase in the number of hospitals, diagnostic centers, and specialty centers are projected to further boost the growth of the mammography market in the future.
Lack of Awareness about Mammography Systems
Despite the growing popularity of mammography for the detection of breast cancer, various challenges are restraining market growth to a large extent. Some of these factors are the risk of radiation exposure, high capital investment, and lack of awareness about mammography systems across some developing and underdeveloped regions of the world.
North America is projected to continue its dominance in the global mammography market owing to the growing prevalence of breast cancer with a market share of 36.7%. Further, rising awareness among people regarding the importance of diagnostic screening for initiating early treatment, and increasing spending by government and private organizations in research and development activities also propel the market growth.
Within North America, the United States remains the most significant market for mammography due to rising cases of breast cancer with a market share of 33.4%. The availability of advanced diagnostic solutions and favorable government support are the important factors that propel market growth.
According to the American Cancer Society around 287,850 new cases of invasive breast cancer cases might be diagnosed across the United States. This is going to continue to expand the size of the mammography market across North America during the forecast period.
According to Future Market Insights, Asia Pacific’s mammography market is expected to witness a high growth rate during the forecast period, owing to the factors such as:
Growing awareness about breast cancer, its diagnosis, and the availability of alternative treatments is playing a key role in spurring the growth of the mammography market across Asia Pacific nations like India and China. Moreover, people are continuously opting for these techniques for the early detection of breast cancer. Once detected, timely treatment can be taken which increases the chances of survival and reduces the economic burden as well.
Governments across these countries are taking various initiatives to reduce the rising burden of breast cancer cases. This is creating a conducive environment for the growth of the mammography market in the region.
Improvements in breast imaging technology and efforts for raising awareness about breast cancer screening are driving Europe’s market. Breast cancer is one of the most common types of cancer in Europe. Because of this, there is a growing need for proper treatment and screening to find breast cancer, so the market is likely to grow over the next few years. Europe forecasts a market share of 28.1%.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The digital technology segment dominates the market with a market share of 63.4% in 2022 and is anticipated to witness substantial growth over the forecast period. Digital mammography is considered to be a specialized and sophisticated form of mammography that helps in examining breast tissue for the presence of cancers.
Hospitals dominated the end-use segment in 2022 with a share of around 47.3% in terms of revenue. The presence of mammography facilities within a hospital positively affects various factors, like duration of hospital stay, total healthcare cost, quality of care, and availability of emergency care.
High admission rates of patients for proper treatment within hospital settings across the globe are likely to continue pushing sales in this segment over the forecast period.
Some of the key participants present in the global mammography market include Allengers Medical Systems Limited, FUJIFILM Holdings America Corporation, Hologic, Inc., PLANNED OY, Konica Minolta, GENERAL ELECTRIC, Inc., Siemens Healthcare Private Limited, Carestream Health, GE Healthcare, Koninklijke Philips N.V., and BET Medical.
These leading players are continuously innovating for developing novel diagnostic products with enhanced features and minimum side effects. Besides this, they are adopting growth strategies such as partnerships, acquisitions, collaborations, spending on awareness campaigns, etc. to gain a competitive edge in the market.
Report Attributes | Details |
---|---|
Growth Rate | CAGR of 10.1% from 2023 to 2033 |
Base Year for Estimation | 2022 |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered | Product Type, Technology Type, End Use, Region |
Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East and Africa |
Key Countries Profiled | The United States, Canada, Brazil, Mexico, Rest of Latin America, Germany, The United Kingdom, France, Spain, Italy, Rest of Western Europe, Poland, Russia, Czech Republic, Romania, Rest of Eastern Europe, India, Bangladesh, Australia, New Zealand, Rest of South Asia and the Pacific, China, Japan, South Korea, GCC countries, South Africa, Israel, Rest of the Middle East and Africa |
Key Companies Profiled | Allengers Medical Systems Limited; FUJIFILM Holdings America Corporation; Hologic, Inc.; PLANMED OY; Konica Minolta, GENERAL ELECTRIC, Inc.; Siemens Healthcare Private Limited; Carestream Health; GE Healthcare; Koninklijke Philips N.V.; BET Medical. |
Customization | Available Upon Request |
The advanced composites market CAGR for 2033 is 10.1%.
The market is estimated to reach USD 4,899.7 billion by 2033.
Players invest in R&D for innovative composites, expand portfolios, enter new markets, partner, and offer customer training for growth.
The market is estimated to secure a valuation of USD 1,880.2 billion in 2023.
Cost, manufacturing complexity, labor shortage, environment worries, and technical hurdles hinder advanced composites' adoption.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Breast Tomosynthesis 5.2. Film Screen Systems 5.3. X-Ray 5.4. Others 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology Type 6.1. Digital 6.2. Analog 6.3. 3-D 6.4. 2-D 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use 7.1. Hospitals 7.2. Special Clinics 7.3. Diagnosis Centers 7.4. Ambulatory Surgical Centers 7.5. Educational & Research Institutes 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Allengers Medical Systems Limited 18.2. FUJIFILM Holdings America Corporation 18.3. Hologic, Inc. 18.4. PLANMED OY 18.5. Konica Minolta, GENERAL ELECTRIC, Inc. 18.6. Siemens Healthcare Private Limited 18.7. Carestream Health 18.8. GE Healthcare 18.9. Koninklijke Philips N.V. 18.10. BET Medical 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports